Goodyear is in the cleanup phase of its Goodyear Forward transformation: it has already sold the Chemical business and other non-core assets, while its Americas tire operation remains under pressure and is undergoing additional manufacturing-footprint reductions. This filing extends that restructuring rather than changing the strategy. Goodyear will close the Niagara Falls and Bayport chemical facilities, eliminate about 85 jobs, and substantially complete the plan by the end of 2027. 〔0〕
| Item | Filing figure |
|---|---|
| Total pre-tax charges | $55M–$75M |
| Expected cash charges | Approximately $30M |
| Expected Q3 2026 charges | Approximately $35M |
| Expected remainder-of-2026 charges | Approximately $15M |
| Annual Americas operating-income improvement from 2027 | $15M–$20M |
The economics are directionally helpful but not transformative. The closures should improve Americas segment operating income by $15–20 million annually beginning in 2027. That is a useful removal of stranded or subscale infrastructure after the Chemical business sale, but it is modest beside Goodyear’s larger Americas footprint actions, including the previously announced Fayetteville closure expected to generate roughly $270 million of annual savings from 2028 onward.
The tradeoff is a long and charge-heavy payback. Goodyear is taking $55–75 million of pre-tax charges for $15–20 million of annual benefit, with most cash outflows occurring by the end of 2027. 〔1〕 The filing therefore adds operational discipline, but it does not provide an immediate earnings lift; the near-term effect is a material restructuring charge followed by gradual savings.
Bottom line: This is a sensible final cleanup of facilities retained after the Chemical business sale, but it is a small efficiency step with meaningful upfront costs rather than a major change to Goodyear’s turnaround story.
Read the original 8-K on SEC EDGAR ↗